Apr 8, 2026, 18:14
Simon Fletcher: The Unique Challenges PwH Face During Their Gene Therapy Journey
Simon Fletcher, Research Assistant at University of Oxford, shared a post on LinkedIn:
“In July I’m going to be in Paris at the ISTH 2026 congress sharing a novel psychosocial care framework for people undergoing gene therapy
for haemophilia.
After five years of research and clinical observation, the Exigency framework has been developed to address the unique challenges PwH face during their gene therapy journey.
What it will cover:
- Pre-treatment assessment
- Post-treatment monitoring
- Multidisciplinary care coordination strategies
- Patient support and education
Join me at the poster session on the 13th July to learn more about how this integrated approach can improve patient outcomes and quality of life.”
Stay updated with Hemostasis Today.
-
Jul 23, 2026, 09:05Fonkou Steve: What If We’ve Been Asking the Wrong Question About Plasma Too?
-
Jul 23, 2026, 08:27Registration Is Now Open for ASH 2026
-
Jul 23, 2026, 08:19Sheeza Nawaz: Why Do Patients With Aortic Stenosis Bleed?
-
Jul 23, 2026, 07:59Paschalis Karakasis: Can Left Atrial Appendage Closure Truly Replace Oral Anticoagulation?
-
Jul 23, 2026, 06:53Lakmali Silva: What Makes ISTH More Than a Scientific Meeting?
-
Jul 23, 2026, 05:48Paschalis Evangelidis: Rethinking Pulmonary Embolism Through the Lens of Thromboinflammation
-
Jul 23, 2026, 05:35Neil Morgan: Honoured to Lead the Platelet and Megakaryocyte Theme at ISTH 2026
-
Jul 23, 2026, 04:42Camilla Oriani: A Memorable First ISTH 2026 in Paris
-
Jul 23, 2026, 03:32Nazlı Pelin Kirkayak: A 9-Year Real-World Analysis of Adult Thrombotic Microangiopathies